Institutional investors purchased a net $337.7 thousand shares of CCXI during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 49.88% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CARMIGNAC GESTION LUXEMBOURG SA ... Bought 390.1 Thousand shares of ChemoCentryx Inc